 | • レポートコード：QYR9ST04976 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、次世代抗体療法の世界市場について調査・分析し、次世代抗体療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体薬物コンジュゲート（ADC）、二重特異性抗体（BsAbs）、Fc工学抗体、抗体フラグメント及び抗体様タンパク質（AF及びALP）、バイオシミラー抗体（Ab）製品）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の次世代抗体療法市場動向 ・主要企業別マーケットシェア ・次世代抗体療法の種類別市場規模2014-2019 （抗体薬物コンジュゲート（ADC）、二重特異性抗体（BsAbs）、Fc工学抗体、抗体フラグメント及び抗体様タンパク質（AF及びALP）、バイオシミラー抗体（Ab）製品） ・次世代抗体療法の用途別市場規模2014-2019 （病院、診療所、その他） ・次世代抗体療法の北米市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法の中国市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法の日本国内市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法のインド市場：主要企業・種類別/用途別市場規模 ・次世代抗体療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Roche、Bristol-Myers Squibb、Amgen、AstraZeneca、Bayer、Takeda Pharmaceuticals、Biogen、Seattle Genetics、ImmunoGen、Kyowa Hakko Kirin、Xencor、Dyax Corp） ・次世代抗体療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.Geographically, North America dominates the next-generation antibody therapeutics market due to growing R&D activities and technological advancements in antibody therapeutics in the region. In addition, the increasing prevalence of chronic diseases and growing healthcare expenditure are fueling the growth of the next-generation antibody therapeutics market in North America. Moreover, the increasing healthcare expenditure is driving the market for next-generation antibody therapeutics in North America.
In 2018, the global Next Generation Antibody Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Antibody Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Bayer
Takeda Pharmaceuticals
Biogen
Seattle Genetics
ImmunoGen
Kyowa Hakko Kirin
Xencor
Dyax Corp
Market segment by Type, the product can be split into
Antibody Drug Conjugates (ADCs)
Bispecific Antibodies (BsAbs)
Fc Engineered Antibodies
Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Biosimilar Antibody (Ab) Products
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Antibody Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Next Generation Antibody Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibody Drug Conjugates (ADCs)
1.4.3 Bispecific Antibodies (BsAbs)
1.4.4 Fc Engineered Antibodies
1.4.5 Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
1.4.6 Biosimilar Antibody (Ab) Products
1.5 Market by Application
1.5.1 Global Next Generation Antibody Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Next Generation Antibody Therapeutics Market Size
2.2 Next Generation Antibody Therapeutics Growth Trends by Regions
2.2.1 Next Generation Antibody Therapeutics Market Size by Regions (2014-2025)
2.2.2 Next Generation Antibody Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Next Generation Antibody Therapeutics Market Size by Manufacturers
3.1.1 Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Antibody Therapeutics Key Players Head office and Area Served
3.3 Key Players Next Generation Antibody Therapeutics Product/Solution/Service
3.4 Date of Enter into Next Generation Antibody Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019)
4.2 Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Next Generation Antibody Therapeutics Market Size (2014-2019)
5.2 Next Generation Antibody Therapeutics Key Players in United States
5.3 United States Next Generation Antibody Therapeutics Market Size by Type
5.4 United States Next Generation Antibody Therapeutics Market Size by Application
6 Europe
6.1 Europe Next Generation Antibody Therapeutics Market Size (2014-2019)
6.2 Next Generation Antibody Therapeutics Key Players in Europe
6.3 Europe Next Generation Antibody Therapeutics Market Size by Type
6.4 Europe Next Generation Antibody Therapeutics Market Size by Application
7 China
7.1 China Next Generation Antibody Therapeutics Market Size (2014-2019)
7.2 Next Generation Antibody Therapeutics Key Players in China
7.3 China Next Generation Antibody Therapeutics Market Size by Type
7.4 China Next Generation Antibody Therapeutics Market Size by Application
8 Japan
8.1 Japan Next Generation Antibody Therapeutics Market Size (2014-2019)
8.2 Next Generation Antibody Therapeutics Key Players in Japan
8.3 Japan Next Generation Antibody Therapeutics Market Size by Type
8.4 Japan Next Generation Antibody Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Next Generation Antibody Therapeutics Market Size (2014-2019)
9.2 Next Generation Antibody Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Next Generation Antibody Therapeutics Market Size by Type
9.4 Southeast Asia Next Generation Antibody Therapeutics Market Size by Application
10 India
10.1 India Next Generation Antibody Therapeutics Market Size (2014-2019)
10.2 Next Generation Antibody Therapeutics Key Players in India
10.3 India Next Generation Antibody Therapeutics Market Size by Type
10.4 India Next Generation Antibody Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Next Generation Antibody Therapeutics Market Size (2014-2019)
11.2 Next Generation Antibody Therapeutics Key Players in Central & South America
11.3 Central & South America Next Generation Antibody Therapeutics Market Size by Type
11.4 Central & South America Next Generation Antibody Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next Generation Antibody Therapeutics Introduction
12.1.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next Generation Antibody Therapeutics Introduction
12.2.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next Generation Antibody Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next Generation Antibody Therapeutics Introduction
12.4.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next Generation Antibody Therapeutics Introduction
12.5.4 AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next Generation Antibody Therapeutics Introduction
12.6.4 Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Takeda Pharmaceuticals
12.7.1 Takeda Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next Generation Antibody Therapeutics Introduction
12.7.4 Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.7.5 Takeda Pharmaceuticals Recent Development
12.8 Biogen
12.8.1 Biogen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next Generation Antibody Therapeutics Introduction
12.8.4 Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.8.5 Biogen Recent Development
12.9 Seattle Genetics
12.9.1 Seattle Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next Generation Antibody Therapeutics Introduction
12.9.4 Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.9.5 Seattle Genetics Recent Development
12.10 ImmunoGen
12.10.1 ImmunoGen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next Generation Antibody Therapeutics Introduction
12.10.4 ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.10.5 ImmunoGen Recent Development
12.11 Kyowa Hakko Kirin
12.12 Xencor
12.13 Dyax Corp
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Next Generation Antibody Therapeutics Key Market Segments
Table Key Players Next Generation Antibody Therapeutics Covered
Table Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type 2014-2025
Figure Antibody Drug Conjugates (ADCs) Figures
Table Key Players of Antibody Drug Conjugates (ADCs)
Figure Bispecific Antibodies (BsAbs) Figures
Table Key Players of Bispecific Antibodies (BsAbs)
Figure Fc Engineered Antibodies Figures
Table Key Players of Fc Engineered Antibodies
Figure Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Figures
Table Key Players of Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Figure Biosimilar Antibody (Ab) Products Figures
Table Key Players of Biosimilar Antibody (Ab) Products
Table Global Next Generation Antibody Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Next Generation Antibody Therapeutics Report Years Considered
Table Global Next Generation Antibody Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019
Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019
Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Share by Manufacturers in 2018
Table Global Next Generation Antibody Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next Generation Antibody Therapeutics Product/Solution/Service
Table Date of Enter into Next Generation Antibody Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size Share by Type (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size Share by Application (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Next Generation Antibody Therapeutics Revenue Market Share by Application in 2018
Figure United States Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table United States Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table United States Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Europe Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Europe Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Europe Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure China Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table China Next Generation Antibody Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table China Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Japan Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Japan Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Japan Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure India Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table India Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table India Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Central & South America Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Central & South America Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Amgen Company Details
Table Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceuticals Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Takeda Pharmaceuticals Recent Development
Table Biogen Company Details
Table Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Seattle Genetics Company Details
Table Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Seattle Genetics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Seattle Genetics Recent Development
Table ImmunoGen Company Details
Table ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure ImmunoGen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table ImmunoGen Recent Development
Table Kyowa Hakko Kirin Company Details
Table Xencor Company Details
Table Dyax Corp Company Details
Table Global Next Generation Antibody Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions in 2025
Figure United States Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size by Product in 2025
Table Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
抗体薬物コンジュゲートの世界市場：インサイト・予測 Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there i…- バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- 世界の二重特異性抗体治療法市場：動向・競争分析 Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads …
- モノクローナル抗体治療薬の世界市場：インサイト・予測 For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.T…
- モノクローナル抗体ベース製品の世界市場：市場規模・現状・予測 Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…